Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clustered mitochondria homolog pseudogene 2 (CLUHP2) is a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they generally do not encode functional proteins due to mutations or the absence of necessary regulatory elements. CLUHP2 does not encode a protein, is not classified as a receptor, enzyme, or other canonical therapeutic target, and no disease associations, molecular functions, or drug interactions are reported in the scientific literature or major gene databases[1]. Note: - This gene is distinct from “Clusterin” (CLU), which is a separate, functional gene with well-characterized roles in human biology and pathology[4]. - No evidence supports CLUHP2 as a functional protein or as a targetable molecule in pharmacology or medicine[1]. - CLUHP2 is not misspelled; however, its status as a pseudogene means it does not have the typical information available for protein-coding gene drug targets[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clustered mitochondria homolog pseudogene 2 (CLUHP2).